2190 logo

Zylox-Tonbridge Medical Technology Co., Ltd. Stock Price

SEHK:2190 Community·HK$8.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

2190 Share Price Performance

HK$25.34
11.78 (86.87%)
HK$25.34
11.78 (86.87%)
Price HK$25.34

2190 Community Narratives

There are no narratives available yet.

Recent 2190 News & Updates

Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Not Lagging Industry On Growth Or Pricing

Sep 24
Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Not Lagging Industry On Growth Or Pricing

The Return Trends At Zylox-Tonbridge Medical Technology (HKG:2190) Look Promising

Aug 13
The Return Trends At Zylox-Tonbridge Medical Technology (HKG:2190) Look Promising

Here's Why Shareholders May Want To Be Cautious With Increasing Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) CEO Pay Packet

May 23
Here's Why Shareholders May Want To Be Cautious With Increasing Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) CEO Pay Packet

Solid Earnings Reflect Zylox-Tonbridge Medical Technology's (HKG:2190) Strength As A Business

May 09
Solid Earnings Reflect Zylox-Tonbridge Medical Technology's (HKG:2190) Strength As A Business

Zylox-Tonbridge Medical Technology Co., Ltd. Key Details

CN¥898.5m

Revenue

CN¥256.4m

Cost of Revenue

CN¥642.1m

Gross Profit

CN¥489.5m

Other Expenses

CN¥152.6m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
0.48
Gross Margin
71.47%
Net Profit Margin
16.98%
Debt/Equity Ratio
2.5%

Zylox-Tonbridge Medical Technology Co., Ltd. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet with high growth potential.

0 Risks
3 Rewards

About 2190

Founded
2012
Employees
875
CEO
Zhong Zhao
WebsiteView website
www.zyloxtb.com

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People’s Republic of China and internationally. The company offers a neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices. Its peripheral-vascular interventional product portfolio includes stents, balloons, catheters, and filters, as well as covers hemodialysis access, arterial, venous, peripheral embolization intervention, and other intervention products. In addition, the company provides technical consultation and services, as well as imports materials. It serves patients and physicians. The company was formerly known as Zhejiang Zylox Medical Device Co., Ltd. and changed its name to Zylox-Tonbridge Medical Technology Co., Ltd. in March 2021. Zylox-Tonbridge Medical Technology Co., Ltd. was incorporated in 2012 and is headquartered in Hangzhou, the People’s Republic of China.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Chinese Market Performance

  • 7 Days: 0.5%
  • 3 Months: 17.0%
  • 1 Year: 24.1%
  • Year to Date: 26.2%
Over the last 7 days, the market has remained flat, with no particular sector making any big moves this week. More promisingly, the market is up 24% over the past year. Earnings are forecast to grow by 27% annually. Market details ›